首页 > 最新文献

Annales de biologie clinique最新文献

英文 中文
Inquilinus limosus, an atypical Gram-negative rod from lung transplant recipients and cystic fibrosis patients. Inquilinus limosus,一种来自肺移植受者和囊性纤维化患者的非典型革兰氏阴性杆菌。
Pub Date : 2024-04-01 DOI: 10.1684/abc.2024.1876
E. Farfour, Stéphane Corvec, Thomas Guillard, Hélène Revillet
{"title":"Inquilinus limosus, an atypical Gram-negative rod from lung transplant recipients and cystic fibrosis patients.","authors":"E. Farfour, Stéphane Corvec, Thomas Guillard, Hélène Revillet","doi":"10.1684/abc.2024.1876","DOIUrl":"https://doi.org/10.1684/abc.2024.1876","url":null,"abstract":"","PeriodicalId":93870,"journal":{"name":"Annales de biologie clinique","volume":"366 3","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140781935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dutcher bodies in a Waldenström Macroglobulinaemia patient. 一名瓦尔登斯特伦巨球蛋白血症患者体内的杜氏体。
Pub Date : 2024-02-24 DOI: 10.1684/abc.2023.1855
Anne Checkouri, Carole Humbert, Yazid Arkam, Agathe Debliquis
{"title":"Dutcher bodies in a Waldenström Macroglobulinaemia patient.","authors":"Anne Checkouri, Carole Humbert, Yazid Arkam, Agathe Debliquis","doi":"10.1684/abc.2023.1855","DOIUrl":"10.1684/abc.2023.1855","url":null,"abstract":"","PeriodicalId":93870,"journal":{"name":"Annales de biologie clinique","volume":"81 6","pages":"651-652"},"PeriodicalIF":0.0,"publicationDate":"2024-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139934643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serological screening for celiac disease, by endomysial antibodies, in patients with rheumatoid arthritis. 通过类风湿性关节炎患者的内膜抗体进行乳糜泻血清学筛查。
Pub Date : 2024-02-24 DOI: 10.1684/abc.2023.1851
Mariam Ghozzi, Fatma Mechi, Alma Ben Salem, Ikram El Ahmer, Donia Rachel Mbarki, Sarra Melayah, Amani Mankai, Ibtissem Ghedira

Celiac disease (CD) and rheumathoid arthritis (RA) are both multi-factorial chronic inflammatory auto-immune diseases. In this retrospective study, we determined the frequency of CD in patients with RA using IgA anti-endomysial antibodies (EmA) and tried to explain this association. Indirect immunofluorescence on human umbilical cord was used to detect EmA in 215 patients with seropositive RA collected over a 4-year-period. Two thousand and five hundred healthy blood donors (HBD) served as control group. Among the 215 patients with RA, 12 (9 females) were found positive for EmA while only 7 were positive for EmA in control group, EmA are significantly more frequent in RA patients than in HBD (5.58% vs. 0.28%, p < 10-6; 95% CI [8.21-54.01]; odds ratio: 21.05). In RA patients, the frequency of EmA was not statistically different between males and females. The frequency of EmA was significantly higher in female patients than in healthy females (5.32% vs. 0.40%, p < 10-3). Patients with RA can be considered as a high-risk group for CD based on the high frequency of EmA positivity observed in our study.

乳糜泻(CD)和类风湿性关节炎(RA)都是多因素慢性自身免疫炎症性疾病。在这项回顾性研究中,我们利用 IgA 抗内膜抗体(EmA)确定了 RA 患者中 CD 的发病频率,并试图解释这种关联。我们用间接免疫荧光法检测了 215 名血清反应阳性 RA 患者脐带中的 EmA,采集时间长达 4 年。2,500 名健康献血者(HBD)作为对照组。在 215 名 RA 患者中,有 12 人(9 名女性)发现 EmA 阳性,而对照组中只有 7 人发现 EmA 阳性。
{"title":"Serological screening for celiac disease, by endomysial antibodies, in patients with rheumatoid arthritis.","authors":"Mariam Ghozzi, Fatma Mechi, Alma Ben Salem, Ikram El Ahmer, Donia Rachel Mbarki, Sarra Melayah, Amani Mankai, Ibtissem Ghedira","doi":"10.1684/abc.2023.1851","DOIUrl":"10.1684/abc.2023.1851","url":null,"abstract":"<p><p>Celiac disease (CD) and rheumathoid arthritis (RA) are both multi-factorial chronic inflammatory auto-immune diseases. In this retrospective study, we determined the frequency of CD in patients with RA using IgA anti-endomysial antibodies (EmA) and tried to explain this association. Indirect immunofluorescence on human umbilical cord was used to detect EmA in 215 patients with seropositive RA collected over a 4-year-period. Two thousand and five hundred healthy blood donors (HBD) served as control group. Among the 215 patients with RA, 12 (9 females) were found positive for EmA while only 7 were positive for EmA in control group, EmA are significantly more frequent in RA patients than in HBD (5.58% vs. 0.28%, p < 10-6; 95% CI [8.21-54.01]; odds ratio: 21.05). In RA patients, the frequency of EmA was not statistically different between males and females. The frequency of EmA was significantly higher in female patients than in healthy females (5.32% vs. 0.40%, p < 10-3). Patients with RA can be considered as a high-risk group for CD based on the high frequency of EmA positivity observed in our study.</p>","PeriodicalId":93870,"journal":{"name":"Annales de biologie clinique","volume":"81 6","pages":"569-575"},"PeriodicalIF":0.0,"publicationDate":"2024-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139934646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[An alarming health check-up: what a bloody plasma!] [令人震惊的健康检查: 真是个该死的血浆!]
Pub Date : 2024-02-24 DOI: 10.1684/abc.2023.1850
Julie Labasque, Dorian Marchand, Clémentine Lhomme, Jacob Lavisse, Patrice Maboudou, Guillaume Grzych

A 35-year-old patient with a metabolic pathology was hospitalized for programmed fibroscopy under general anesthesia for investigation and management of portal hypertension. Following the operation, he showed signs of sepsis and was transferred to intensive care unit. Biological analyzes carried out and generated automaton alarms for certain parameters. A visual check of the appearance of the sample revealed an unusual color of plasma. Additional informations obtained from the clinical department did not provide any explanation for this coloration. Additional assays confirmed an overdose of vitamin B12 related to the treatment of his pathology and which is responsible for the interference observed. Hence the interest of checking the reaction curves in the event of suspected interference and, if necessary, of making dilutions in order to reduce the effects on the biological assays.

一名 35 岁的代谢性病变患者因门静脉高压症住院,在全身麻醉的情况下接受了程控纤维镜检查。手术后,他出现了败血症症状,被转入重症监护室。对某些参数进行了生物分析并发出自动警报。对样本外观的目测发现血浆颜色异常。从临床科室获得的其他信息无法解释这种颜色。其他化验结果证实,该病人在病理治疗过程中服用了过量的维生素 B12,这也是造成所观察到的干扰的原因。因此,在怀疑存在干扰的情况下,有必要检查反应曲线,必要时进行稀释,以减少对生物检测的影响。
{"title":"[An alarming health check-up: what a bloody plasma!]","authors":"Julie Labasque, Dorian Marchand, Clémentine Lhomme, Jacob Lavisse, Patrice Maboudou, Guillaume Grzych","doi":"10.1684/abc.2023.1850","DOIUrl":"10.1684/abc.2023.1850","url":null,"abstract":"<p><p>A 35-year-old patient with a metabolic pathology was hospitalized for programmed fibroscopy under general anesthesia for investigation and management of portal hypertension. Following the operation, he showed signs of sepsis and was transferred to intensive care unit. Biological analyzes carried out and generated automaton alarms for certain parameters. A visual check of the appearance of the sample revealed an unusual color of plasma. Additional informations obtained from the clinical department did not provide any explanation for this coloration. Additional assays confirmed an overdose of vitamin B12 related to the treatment of his pathology and which is responsible for the interference observed. Hence the interest of checking the reaction curves in the event of suspected interference and, if necessary, of making dilutions in order to reduce the effects on the biological assays.</p>","PeriodicalId":93870,"journal":{"name":"Annales de biologie clinique","volume":"81 6","pages":"653-656"},"PeriodicalIF":0.0,"publicationDate":"2024-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139378985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Myeloma mimicking acute leukemia. 模仿急性白血病的骨髓瘤
Pub Date : 2024-02-24 DOI: 10.1684/abc.2023.1856
Maroua Mabrouk, Lucile Baseggio
{"title":"Myeloma mimicking acute leukemia.","authors":"Maroua Mabrouk, Lucile Baseggio","doi":"10.1684/abc.2023.1856","DOIUrl":"10.1684/abc.2023.1856","url":null,"abstract":"","PeriodicalId":93870,"journal":{"name":"Annales de biologie clinique","volume":"81 6","pages":"649-650"},"PeriodicalIF":0.0,"publicationDate":"2024-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139934645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The mRNA of solute carrier family 22, member 17 (SLC22A17) plays the potential diagnostic and prognostic role in advantage non-small cell lung cancer patients. 溶质运载体家族 22 成员 17(SLC22A17)的 mRNA 在非小细胞肺癌患者中具有潜在的诊断和预后作用。
Pub Date : 2024-02-24 DOI: 10.1684/abc.2023.1861
Wenwen Qin, Cuimin Ding, Fei Peng, Ping Wang

This study aims to evaluate the mRNA levels of solute carrier family 22, member 17 (SLC22A17) and its potential clinical value as a diagnostic and prognostic biomarker in non-small cell lung cancer. This prospective study measured SLC22A17 mRNA levels in lung cancer and paracancer tissues using quantitative reverse transcription-polymerase chain reaction (PCR). The levels of SLC22A17 mRNA in plasma samples from healthy control subjects and patients with lung cancer were also measured. The association between SLC22A17 mRNA levels in plasma and clinicopathological characteristics was determined. Receiver operating characteristic (ROC) curve analysis was performed to determine the diagnostic value of SLC22A17 in plasma. Survival curve analysis was performed using the Kaplan-Meier method. SLC22A17 mRNA levels were significantly higher in lung cancer samples than in the paired paracancerous tissues. Plasma SLC22A17 mRNA levels were also significantly higher in patients with lung cancer than in healthy controls. The COX analysis indicated that there was a significant correlation between elevated plasma SLC22A17 mRNA levels and lymph node metastasis, distant metastasis, and TNM stage. Furthermore, the ROC curve analysis demonstrated that plasma SLC22A17 had high diagnostic value. High plasma SLC22A17 mRNA levels are associated with a significantly shorter survival time. SLC22A17 is upregulated in lung cancer and may serve as a novel diagnostic and prognostic biomarker.

本研究旨在评估溶质运载家族 22 成员 17(SLC22A17)的 mRNA 水平及其作为非小细胞肺癌诊断和预后生物标志物的潜在临床价值。这项前瞻性研究采用定量反转录聚合酶链反应(PCR)技术测定了肺癌和癌旁组织中的 SLC22A17 mRNA 水平。同时还测定了健康对照组和肺癌患者血浆样本中的 SLC22A17 mRNA 水平。测定了血浆中 SLC22A17 mRNA 水平与临床病理特征之间的关联。为确定血浆中 SLC22A17 的诊断价值,进行了接收者操作特征(ROC)曲线分析。采用 Kaplan-Meier 法进行生存曲线分析。肺癌样本中的SLC22A17 mRNA水平明显高于配对的癌旁组织。肺癌患者血浆中的SLC22A17 mRNA水平也明显高于健康对照组。COX分析表明,血浆SLC22A17 mRNA水平升高与淋巴结转移、远处转移和TNM分期之间存在显著相关性。此外,ROC 曲线分析表明,血浆 SLC22A17 具有很高的诊断价值。血浆SLC22A17 mRNA水平高与生存时间明显缩短相关。SLC22A17在肺癌中上调,可作为一种新型诊断和预后生物标志物。
{"title":"The mRNA of solute carrier family 22, member 17 (SLC22A17) plays the potential diagnostic and prognostic role in advantage non-small cell lung cancer patients.","authors":"Wenwen Qin, Cuimin Ding, Fei Peng, Ping Wang","doi":"10.1684/abc.2023.1861","DOIUrl":"10.1684/abc.2023.1861","url":null,"abstract":"<p><p>This study aims to evaluate the mRNA levels of solute carrier family 22, member 17 (SLC22A17) and its potential clinical value as a diagnostic and prognostic biomarker in non-small cell lung cancer. This prospective study measured SLC22A17 mRNA levels in lung cancer and paracancer tissues using quantitative reverse transcription-polymerase chain reaction (PCR). The levels of SLC22A17 mRNA in plasma samples from healthy control subjects and patients with lung cancer were also measured. The association between SLC22A17 mRNA levels in plasma and clinicopathological characteristics was determined. Receiver operating characteristic (ROC) curve analysis was performed to determine the diagnostic value of SLC22A17 in plasma. Survival curve analysis was performed using the Kaplan-Meier method. SLC22A17 mRNA levels were significantly higher in lung cancer samples than in the paired paracancerous tissues. Plasma SLC22A17 mRNA levels were also significantly higher in patients with lung cancer than in healthy controls. The COX analysis indicated that there was a significant correlation between elevated plasma SLC22A17 mRNA levels and lymph node metastasis, distant metastasis, and TNM stage. Furthermore, the ROC curve analysis demonstrated that plasma SLC22A17 had high diagnostic value. High plasma SLC22A17 mRNA levels are associated with a significantly shorter survival time. SLC22A17 is upregulated in lung cancer and may serve as a novel diagnostic and prognostic biomarker.</p>","PeriodicalId":93870,"journal":{"name":"Annales de biologie clinique","volume":"81 6","pages":"602-609"},"PeriodicalIF":0.0,"publicationDate":"2024-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139934647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic effects of finasteride: inhibition of disease progression and serum prostate-specific antigen reduction in patients with prostatic intraepithelial neoplasia. 非那雄胺的治疗效果:抑制前列腺上皮内瘤变患者的疾病进展并降低血清前列腺特异性抗原。
Pub Date : 2024-02-24 DOI: 10.1684/abc.2023.1859
Jia Wei He, Zi-Xuan Huang, Jian-Liang Wu, Yan-Feng Su, Xiao-Long Xu

The objective of this study was to evaluate the impact of finasteride on the progression of prostate intraepithelial neoplasia and levels of prostate-specific antigen (PSA) in patients. A total of 120 patients with high-grade prostatic intraepithelial neoplasia were included in this study from January 2013 to January 2018. All patients underwent prostate biopsies. Among them, 60 patients were assigned to the observation group and received a daily dosage of 5 mg finasteride for 60 months, while the remaining 60 patients were assigned to the control group and did not receive finasteride. PSA levels were measured every six months, and imaging scans were conducted throughout the five-year study period. Additional biopsies were performed if PSA levels exceeded 10 ng/mL or imaging suggested the presence of prostate cancer. Statistical analysis was applied to the collected data. In total, 25 cases of prostate cancer were identified in this study. Of these cases, 7 patients belonged to the observation group, whereas the remaining 18 patients were from the control group. The observation group exhibited significantly lower levels of total serum PSA (p < 0.001) and Gleason scores (p < 0.001) compared to the control group. Our study, which involved 120 participants, demonstrated that finasteride effectively reduces serum PSA levels and mitigates the severity of prostate cancer. These findings suggest that finasteride holds potential as a treatment option for patients with -high-grade prostatic intraepithelial neoplasia.

本研究旨在评估非那雄胺对患者前列腺上皮内瘤变进展和前列腺特异性抗原(PSA)水平的影响。本研究共纳入了120例高级别前列腺上皮内瘤变患者,时间为2013年1月至2018年1月。所有患者均接受了前列腺活检。其中,60名患者被分配到观察组,每天服用5毫克非那雄胺,持续60个月;其余60名患者被分配到对照组,不服用非那雄胺。在为期五年的研究期间,每六个月测量一次PSA水平,并进行成像扫描。如果PSA水平超过10纳克/毫升,或成像显示存在前列腺癌,则进行额外的活组织检查。对收集到的数据进行了统计分析。本研究共发现 25 例前列腺癌病例。其中 7 例属于观察组,其余 18 例属于对照组。观察组的血清总 PSA 水平明显低于对照组(p
{"title":"Therapeutic effects of finasteride: inhibition of disease progression and serum prostate-specific antigen reduction in patients with prostatic intraepithelial neoplasia.","authors":"Jia Wei He, Zi-Xuan Huang, Jian-Liang Wu, Yan-Feng Su, Xiao-Long Xu","doi":"10.1684/abc.2023.1859","DOIUrl":"10.1684/abc.2023.1859","url":null,"abstract":"<p><p>The objective of this study was to evaluate the impact of finasteride on the progression of prostate intraepithelial neoplasia and levels of prostate-specific antigen (PSA) in patients. A total of 120 patients with high-grade prostatic intraepithelial neoplasia were included in this study from January 2013 to January 2018. All patients underwent prostate biopsies. Among them, 60 patients were assigned to the observation group and received a daily dosage of 5 mg finasteride for 60 months, while the remaining 60 patients were assigned to the control group and did not receive finasteride. PSA levels were measured every six months, and imaging scans were conducted throughout the five-year study period. Additional biopsies were performed if PSA levels exceeded 10 ng/mL or imaging suggested the presence of prostate cancer. Statistical analysis was applied to the collected data. In total, 25 cases of prostate cancer were identified in this study. Of these cases, 7 patients belonged to the observation group, whereas the remaining 18 patients were from the control group. The observation group exhibited significantly lower levels of total serum PSA (p < 0.001) and Gleason scores (p < 0.001) compared to the control group. Our study, which involved 120 participants, demonstrated that finasteride effectively reduces serum PSA levels and mitigates the severity of prostate cancer. These findings suggest that finasteride holds potential as a treatment option for patients with -high-grade prostatic intraepithelial neoplasia.</p>","PeriodicalId":93870,"journal":{"name":"Annales de biologie clinique","volume":"81 6","pages":"610-620"},"PeriodicalIF":0.0,"publicationDate":"2024-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139934648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MALDI-TOF mass spectrometry identification and antifungal susceptibility testing of yeasts causing vulvovaginal candidiasis (VVC) in Tebessa (Northeastern Algeria). 用 MALDI-TOF 质谱鉴定和测试阿尔及利亚东北部 Tebessa 地区引起外阴阴道念珠菌病 (VVC) 的酵母菌的抗真菌药敏性。
Pub Date : 2024-02-24 DOI: 10.1684/abc.2023.1852
Mabrouka Benhadj, Taha Menasria, Stéphane Ranque

Vulvovaginal candidiasis (VVC) alongside with antifungal resistance are becoming a major clinical problem in recent years. A prospective study aimed to evaluate the diversity of yeast strains associated with VVC in Tebessa city (northeastern Algeria) and investigate their susceptibility patterns. Over two months, yeasts were isolated on chromogenic medium from twenty-nine non-pregnant women with symptomatic VVC. The isolates were characterized with MALDI-TOF MS and antifungal susceptibility testing was performed for nine antifungal drugs using SensititreTM YeastOneTM YO10. Twenty-nine non-duplicate yeasts were recovered and the mass spectrometry profiles showed reliable scores of which four genera and five different species were identified. Candida albicans accounted for 65.5 % (n = 19) of the total number of isolates, followed by C. glabrata with 20.7% (n = 6). For the remaining non-albicans Candida (NCA) species, Kluyveromyces marxianus with 6.9% (n = 2), Pichia kudriavzevii and Saccharomyces cerevisiae with one isolate each. The antifungal susceptibilities showed wild type MICs of C. albicans to amphotericin B, azoles and echinocandins. In addition, four C. albicans isolates were resistant to flucytosine. For C. glabrata isolates, 100% non-WT phenotype was found for both posaconazole and itraconazole. For the very first time, the obtained outcomes bring out new data concerning the epidemiology of yeasts causing VVC in Algeria and their antimicrobial susceptibility profiles.

近年来,外阴阴道念珠菌病(VVC)与抗真菌耐药性并存,正在成为一个主要的临床问题。一项前瞻性研究旨在评估特贝萨市(阿尔及利亚东北部)与外阴阴道念珠菌病相关的酵母菌株的多样性,并调查它们的药敏模式。在两个多月的时间里,从 29 名有症状的 VVC 非孕妇身上的发色培养基上分离出了酵母菌。用 MALDI-TOF MS 对分离物进行了表征,并使用 SensititreTM YeastOneTM YO10 对九种抗真菌药物进行了抗真菌药敏试验。回收了 29 种不重复的酵母菌,质谱图显示了可靠的评分,其中确定了 4 个属和 5 个不同的种。白念珠菌占分离菌株总数的 65.5%(n = 19),其次是光滑念珠菌,占 20.7%(n = 6)。在其余的非白色念珠菌(NCA)中,马克西酵母菌(Kluyveromyces marxianus)占 6.9%(n = 2),Pichia kudriavzevii 和酿酒酵母菌(Saccharomyces cerevisiae)各占 1 个分离株。抗真菌药敏试验表明,白僵菌对两性霉素 B、唑类和棘白菌素的 MIC 均为野生型。此外,4 个白僵菌分离株对氟尿嘧啶有抗药性。对于 C. glabrata 分离物,发现泊沙康唑和伊曲康唑都具有 100% 的非 WT 表型。所获得的结果首次提供了有关阿尔及利亚导致 VVC 的酵母菌流行病学及其抗菌药敏感性特征的新数据。
{"title":"MALDI-TOF mass spectrometry identification and antifungal susceptibility testing of yeasts causing vulvovaginal candidiasis (VVC) in Tebessa (Northeastern Algeria).","authors":"Mabrouka Benhadj, Taha Menasria, Stéphane Ranque","doi":"10.1684/abc.2023.1852","DOIUrl":"10.1684/abc.2023.1852","url":null,"abstract":"<p><p>Vulvovaginal candidiasis (VVC) alongside with antifungal resistance are becoming a major clinical problem in recent years. A prospective study aimed to evaluate the diversity of yeast strains associated with VVC in Tebessa city (northeastern Algeria) and investigate their susceptibility patterns. Over two months, yeasts were isolated on chromogenic medium from twenty-nine non-pregnant women with symptomatic VVC. The isolates were characterized with MALDI-TOF MS and antifungal susceptibility testing was performed for nine antifungal drugs using SensititreTM YeastOneTM YO10. Twenty-nine non-duplicate yeasts were recovered and the mass spectrometry profiles showed reliable scores of which four genera and five different species were identified. Candida albicans accounted for 65.5 % (n = 19) of the total number of isolates, followed by C. glabrata with 20.7% (n = 6). For the remaining non-albicans Candida (NCA) species, Kluyveromyces marxianus with 6.9% (n = 2), Pichia kudriavzevii and Saccharomyces cerevisiae with one isolate each. The antifungal susceptibilities showed wild type MICs of C. albicans to amphotericin B, azoles and echinocandins. In addition, four C. albicans isolates were resistant to flucytosine. For C. glabrata isolates, 100% non-WT phenotype was found for both posaconazole and itraconazole. For the very first time, the obtained outcomes bring out new data concerning the epidemiology of yeasts causing VVC in Algeria and their antimicrobial susceptibility profiles.</p>","PeriodicalId":93870,"journal":{"name":"Annales de biologie clinique","volume":"81 6","pages":"576-584"},"PeriodicalIF":0.0,"publicationDate":"2024-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139378989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[RE : « Conversation entre un biologiste clinicien et une intelligence artificielle sur les biomarqueurs du cancer de la prostate »]. [RE: "临床生物学家与人工智能就前列腺癌生物标记物的对话"].
Pub Date : 2024-02-24 DOI: 10.1684/abc.2023.1849
Hinpetch Daungsupawong, Viroj Wiwanitkit
{"title":"[RE : « Conversation entre un biologiste clinicien et une intelligence artificielle sur les biomarqueurs du cancer de la prostate »].","authors":"Hinpetch Daungsupawong, Viroj Wiwanitkit","doi":"10.1684/abc.2023.1849","DOIUrl":"10.1684/abc.2023.1849","url":null,"abstract":"","PeriodicalId":93870,"journal":{"name":"Annales de biologie clinique","volume":"81 6","pages":"660-661"},"PeriodicalIF":0.0,"publicationDate":"2024-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139378987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Integrating pathology and biology into medical education: current state and future directions]. [将病理学和生物学融入医学教育:现状与未来方向]。
Pub Date : 2024-02-24 DOI: 10.1684/abc.2023.1857
Asmaa Tazi, Marion Rabant, Cédric Lemogne, Martin Flamant, Alain Cariou, Stéphanie Baron, Caroline Prot-Bertoye

Pathology and biology are essential in the patient care. However, they suffer from a lack of attractiveness to medicine students. In order to gain insight and improve the visibility and attractiveness of these specialties, we designed a survey and submitted forms to medical students, laboratory medical staff, and clinical staff from the different hospitals and institutes attached to "Université Paris Cité". The responses (363 students (response rate: 9.1%), 109 medical -laboratory staff (25%), 61 clinical staff (10%)) confirmed the poor visibility of these specialties among students as well as the will of the -medical laboratory staff to be more involved in the student's training. The -development of partnerships between laboratories and clinical -departments, which would allow medical students to spend short periods of time in related laboratories during their clinical internship, is a prospect for improving the teaching of these disciplines. The main expected benefits are to "discover a new specialty" and "to better understand the prescription of laboratory tests", which are crucial aspects for understanding the role of laboratory disciplines and their interaction with clinicians to improve patient care.

病理学和生物学对病人护理至关重要。然而,它们对医科学生缺乏吸引力。为了深入了解并提高这些专业的知名度和吸引力,我们设计了一份调查表,并提交给 "巴黎城市大学 "下属各医院和研究所的医学生、实验室医务人员和临床工作人员。调查结果显示(363 名学生(回复率:9.1%)、109 名实验室医务人员(25%)、61 名临床医务人员(10%)),这些专业在学生中的知名度很低,而实验室医务人员则希望更多地参与学生的培训。实验室与临床科室之间建立合作关系,允许医学生在临床实习期间在相关实验室进行短期实习,是改善这些学科教学的一个前景。预期的主要益处是 "发现一门新的专业 "和 "更好地理解实验室检验处方",这对于理解实验室学科的作用及其与临床医生的互动以改善病人护理至关重要。
{"title":"[Integrating pathology and biology into medical education: current state and future directions].","authors":"Asmaa Tazi, Marion Rabant, Cédric Lemogne, Martin Flamant, Alain Cariou, Stéphanie Baron, Caroline Prot-Bertoye","doi":"10.1684/abc.2023.1857","DOIUrl":"10.1684/abc.2023.1857","url":null,"abstract":"<p><p>Pathology and biology are essential in the patient care. However, they suffer from a lack of attractiveness to medicine students. In order to gain insight and improve the visibility and attractiveness of these specialties, we designed a survey and submitted forms to medical students, laboratory medical staff, and clinical staff from the different hospitals and institutes attached to \"Université Paris Cité\". The responses (363 students (response rate: 9.1%), 109 medical -laboratory staff (25%), 61 clinical staff (10%)) confirmed the poor visibility of these specialties among students as well as the will of the -medical laboratory staff to be more involved in the student's training. The -development of partnerships between laboratories and clinical -departments, which would allow medical students to spend short periods of time in related laboratories during their clinical internship, is a prospect for improving the teaching of these disciplines. The main expected benefits are to \"discover a new specialty\" and \"to better understand the prescription of laboratory tests\", which are crucial aspects for understanding the role of laboratory disciplines and their interaction with clinicians to improve patient care.</p>","PeriodicalId":93870,"journal":{"name":"Annales de biologie clinique","volume":"81 6","pages":"628-639"},"PeriodicalIF":0.0,"publicationDate":"2024-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139934612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annales de biologie clinique
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1